Drugs / Strep A AS37
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07085702 | Jul 2025 → Nov 2026 expected | streptococcal infection | GlaxoSmithKline | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Strep A AS37 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07085702 ↗ |
| Modality | Vaccine | “Low dose Strep A AS37 vaccine will be administered IM” NCT07085702 ↗ |
| Route | Intramuscular | “administered IM” NCT07085702 ↗ |